T. Rowe Price Investment Management, Inc. Monte Rosa Therapeutics, Inc. Transaction History

T. Rowe Price Investment Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$4.53 - $8.4 $7.68 Million - $14.2 Million	-1,695,701 Reduced 98.76%	21,364 $147,000
Q1 2023 May 15, 2023	SELL	$5.95 - $8.21 $1.29 Million - $1.79 Million	-217,474 Reduced 11.24%	1,717,065 $13.4 Million
Q4 2022 Feb 14, 2023	BUY	$6.71 - $9.72 $65,496 - $94,876	9,761 Added 0.51%	1,934,539 $14.7 Million
Q3 2022 Nov 14, 2022	BUY	$7.17 - $12.16 $13.8 Million - $23.4 Million	1,924,778 New	1,924,778 $15.7 Million

107

53.8M

276K

15.9K

Ticker GLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,713,900
Market Cap $283M
Description
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.